Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinomas (PDAC) represent one of the deadliest cancers worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments.

Detalles Bibliográficos
Autores principales: Osei-Bordom, Daniel C., Sachdeva, Gagandeep, Christou, Niki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795626/
https://www.ncbi.nlm.nih.gov/pubmed/35096878
http://dx.doi.org/10.3389/fmed.2021.788869

Ejemplares similares

Ejemplares similares